Document Detail


Magnesium sulfate potentiates several cardiovascular and metabolic actions of terbutaline.
MedLine Citation:
PMID:  8131528     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
beta-Adrenergic agonists are useful for the emergency treatment of asthma. Recently, magnesium sulfate (MgSO4) has also been shown to be efficacious in this situation. beta-Agonists have unwanted cardiovascular and metabolic actions: increased systolic blood pressure, corrected QT interval (QTc), serum glucose and insulin, and decreased RR interval, diastolic blood pressure, serum potassium, phosphate, and calcium. As beta-agonists and MgSO4 quite possibly will be used in combination, we sought to determine how MgSO4 would affect these actions. Healthy young male adults were administered two doses of terbutaline sulfate, 0.25 mg subcutaneously, 30 min apart on two separate occasions, in a randomized, double-blind fashion. On one occasion, 4 g of MgSO4 was administered intravenously over the same 30-min period. On the other, normal saline solution was given as a placebo. Cardiovascular and metabolic variables were measured sequentially for 2 h. Data at 60 min with p values given for a summation of all time points are as follows: MgSO4 increased terbutaline's effects on the RR interval by 0.09 s, p < 0.0001; QTc interval by 0.01 s, p < 0.0007; diastolic blood pressure by 8 mm Hg, p = 0.0001; serum calcium by 0.13 mg/dl, p = 0.01; and glucose by 9 mg/dl, p < 0.0001. MgSO4 also mitigated the systolic blood pressure elevating the effect of terbutaline by 5 mm Hg (p = 0.007). The magnitude of the response potentiations was modest. We conclude that combining terbutaline and MgSO4 is unlikely to result in serious short-term adverse events, if used acutely in patients with relatively normal cardiac and metabolic function. MgSO4 may act by potentiating the effect of beta-agonists on magnesium requiring enzymes such as adenyl cyclase.
Authors:
M S Skorodin; P C Freebeck; B Yetter; J E Nelson; W B Van de Graaff; J M Walsh
Related Documents :
6270628 - Catecholamine-induced vasodilator metabolite release from guinea-pig hearts is not due ...
33298 - Pharmacologic antagonism of beta-adrenergic blockade in dogs. i. hemodynamic effects of...
3946248 - Hemodynamics of metoprolol and pindolol in systemic hypertension with particular refere...
24943578 - Sappire: a prototype mobile tool for pressure ulcer risk assessment.
1951518 - Antepartum fetal surveillance tests during sickle cell crisis.
2715998 - Pseudotumor cerebri in systemic lupus erythematosus.
Publication Detail:
Type:  Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, U.S. Gov't, Non-P.H.S.    
Journal Detail:
Title:  Chest     Volume:  105     ISSN:  0012-3692     ISO Abbreviation:  Chest     Publication Date:  1994 Mar 
Date Detail:
Created Date:  1994-04-15     Completed Date:  1994-04-15     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  0231335     Medline TA:  Chest     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  701-5     Citation Subset:  AIM; IM    
Affiliation:
Department of Veterans Affairs, Edward Hines Jr Hospital, Hines, Ill.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Blood Glucose / drug effects
Calcium / blood
Double-Blind Method
Drug Synergism
Drug Therapy, Combination
Hemodynamics / drug effects*
Humans
Magnesium / blood
Magnesium Sulfate / pharmacology*
Male
Phosphates / blood
Potassium / blood
Terbutaline / pharmacology*
Time Factors
Chemical
Reg. No./Substance:
0/Blood Glucose; 0/Phosphates; 23031-25-6/Terbutaline; 7439-95-4/Magnesium; 7440-09-7/Potassium; 7440-70-2/Calcium; 7487-88-9/Magnesium Sulfate

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Bronchodilating effect of terbutaline powder in acute severe bronchial obstruction.
Next Document:  Airway response to a bronchodilator in healthy parents of infants with bronchiolitis.